How to appeal a Humana bph procedures + medical therapy denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for bph procedures + medical therapy

Cited policy: Humana Medical Coverage: Optilume BPH Drug-Coated Balloon

Age >=50 yr with LUTS attributed to BPH, IPSS >=13, prostate 20-80 cc, no obstructive median lobe, Qmax 5-12 mL/s, refractory or intolerant to medical therapy.

How Humana denies bph procedures + medical therapy — and how to counter it

Where Humana pushes back: 1) Too new — insufficient long-term data; 2) Experimental despite FDA approval; 3) Use UroLift or Rezum first; 4) Paclitaxel safety concerns.

Counter-arguments that hold up: Optilume BPH FDA-approved Jun 30, 2023 (Urotronic PMA P220033) — first paclitaxel drug-coated balloon for BPH. PINNACLE prospective double-blind sham-controlled RCT (Kaplan J Urol Sep 2023) — 76.6% responder rate (>=30% IPSS improvement) vs 33.3% sham (P<.001), median IPSS reduction 11.5 vs 4.8, Qmax 8.9 → 19.0 mL/s (113% improvement). 2-yr durability published Prostate Cancer Prostatic Dis 2024 (Nature). AUA 2023 amendment acknowledges drug-coated-balloon class. EVEREST trial supportive data.

What Humana typically denies for bph procedures + medical therapy

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For bph procedures + medical therapy, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the bph procedures + medical therapy treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UroLift
• Rezum
• Aquablation
• iTind
• Optilume BPH
• GreenLight PVP

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.